I

(redirected from prostate cancer)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

I

Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.

I

1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved

i

Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Wall Street Words: An A to Z Guide to Investment Terms for Today's Investor by David L. Scott. Copyright © 2003 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Anyone with concerns can also contact Prostate Cancer UK's specialist nurses in confidence on 0800 074 8383 or visit prostatecanceruk.org.
But men should also be mindful of their family histories with other cancers, as men may be at a greater risk of getting prostate cancer if their families have a history of breast cancer, colon cancer or pancreatic cancer.
In one study, researchers found that men with a brother who had prostate cancer were more than twice as likely as men in the general population to be diagnosed with the disease themselves; those with both a father and brother who had prostate cancer faced about a threefold greater risk (Journal of the National Cancer Institute, October 2016).
'Prostate cancer is the least common among Asian men and most common among black men.
Nearly every medical doctor in the world will tell you that testosterone is somehow 'bad' for your prostate and makes prostate cancer grow.
As Pharma Times recently reported, prostate cancer is now the most common cancer in men in the UK and is the third most common cause of cancer deaths in the UK, with more men dying from the disease than women from breast cancer.
Prostate cancer is the most common cancer in men, killing one man every 45 minutes in the UK.
ZERO is the leading national nonprofit with the mission to end prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action.
Prostate cancer begins when cells in the prostate gland start to grow uncontrollably.
Complementary and Alternative Medicines in Prostate Cancer